Dr. Fearon went further to note the study's implications: "Thus, the BIDI® Stick ENDS may be a satisfying alternative to cigarettes among current adult smokers, including those that find it difficult to quit or who are not interested in quitting smoking."
Comparing published research on other ENDS and tobacco-containing "heat-not-burn" products, study authors said the BIDI® Stick may have a greater ability to satisfy adult smokers looking for alternative, non-combustible sources of nicotine. Researchers completed the clinical "pharmacokinetic" or "PK" study in August of this year to assess both the kinetics of nicotine uptake and the subjective experiences in smokers when they used the BIDI® Stick.
The research paper, which is titled "A Randomized, Crossover Clinical Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the BIDI® Stick ENDS Compared with Combustible Cigarettes and a Comparator ENDS in Adult Smokers," described the findings from a study in adult smokers aged 21 to 65 who smoked at least 10 factory manufactured cigarettes a day.
In a U.S. Food and Drug Administration ("FDA") media briefing held in March 2018, Mitch Zeller, director of the FDA's Center for Tobacco Products (CTP) called combustible cigarettes the "deadliest" but "most efficient way to deliver nicotine." Zeller has gone on to say that e-cigarettes have yet to reach the level of providing the satisfaction smokers want. However, Bidi Vapor's and Kaival Brand's management believe that time may have come.
https://www.prnewswire.com/news-releases/bidi-vapors-ends-potentially-satisfies-adult-cigarette-smokers-study-says-301432635.html